u/adnan_karlsen

Mechanistically the bit that matters is titration.

Disagree on that part. 97.9% and 97.6% on the same vial is normal.

pens are overpriced, research vials are research grade, same molecule different price

Came off after 24 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.

everything else in the vial drawer, research peptides

Stalled for 9 weeks, changed nothing, and it started moving again on week 64.

constipation is real, boring, and fixable

That is net peptide content, not purity. Different number, different meaning.

Yeah, glycaemic control is the original use.

You have restated the marketing copy. What is the actual substance here.

Week 73 for me and the honest summary is: 33kg down, constipation manageable, and the quiet happened around week 24.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

resting heart rate moved up 7 bpm and settled back down when I stopped escalating

Poland here. Waited 19 months on a list, gave up, went private, and the total cost was roughly what I expected.

This order history matches mine almost exactly.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

hypoglycaemia risk when stacked with metformin

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.

Tried the split-dose thing for 11 weeks. Felt slightly smoother, lost at exactly the same rate. Went back to weekly.

The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.

Slight fix: the number was 98.1, not 98.0. Decimal point, but a fairly consequential one.

Cosigning the evidence standard. Receipts make the community.

my ALT moved before the scale did and i nearly missed it